Cargando…

Identification of CXCL5 expression as a predictive biomarker associated with response and prognosis of immunotherapy in patients with non‐small cell lung cancer

BACKGROUND: The breakthrough of immunotherapy has revolutionized the treatment of non‐small cell lung cancer (NSCLC). However, only a limited part of patients could derive clinical benefits. To study how immune microenvironment (IME) of patients could influence the therapeutic efficacy of immunother...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Jie, Ma, Xuejiao, Ni, Yang, Li, Xiaomin, Xi, Wenjing, Tian, Minqi, Zhang, Xing, Xiang, Manyu, Deng, Wanglong, Song, Chao, Wu, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041069/ https://www.ncbi.nlm.nih.gov/pubmed/35150082 http://dx.doi.org/10.1002/cam4.4567

Ejemplares similares

Up-regulation of CXCL8 expression is associated with a poor prognosis and enhances tumor cell malignant behaviors in liver cancer
por: Yang, Song, et al.
Publicado: (2020)

Serum CXCL5 level is associated with tumor progression in penile cancer
por: Mo, Miao, et al.
Publicado: (2021)

CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer
por: Du, Qiang, et al.
Publicado: (2018)

CXCL9: evidence and contradictions for its role in tumor progression
por: Ding, Qiang, et al.
Publicado: (2016)

Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma
por: Hu, Wanming, et al.
Publicado: (2022)

LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis
por: Tian, Shubo, et al.
Publicado: (2020)

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer
por: Gong, Zhe, et al.
Publicado: (2020)

Integration of comprehensive genomic profiling, tumor mutational burden, and PD‐L1 expression to identify novel biomarkers of immunotherapy in non‐small cell lung cancer
por: Shi, Yunfei, et al.
Publicado: (2021)

Interferon gamma in cancer immunotherapy
por: Ni, Ling, et al.
Publicado: (2018)

Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma
por: Xiao, Liang, et al.
Publicado: (2019)

The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution
por: Wang, Gui-Zhen, et al.
Publicado: (2015)

CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2016)

The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways
por: Tian, Xin‐Yuan, et al.
Publicado: (2020)

Prediction of prognosis of patients with lung cancer in combination with the immune score
por: Han, Ke, et al.
Publicado: (2021)

Harnessing neutrophil plasticity for HCC immunotherapy
por: Ramon-Gil, Erik, et al.
Publicado: (2023)

Identification of tRNA‐derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple‐negative breast cancer
por: Feng, Wanting, et al.
Publicado: (2018)

Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer
por: Yan, Xue, et al.
Publicado: (2020)

Tryptophan metabolism and disposition in cancer biology and immunotherapy
por: Badawy, Abdulla A.-B.
Publicado: (2022)

Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p/HNF4α axis via RAS/RAF/MEK/ERK signaling pathway in pediatric neuroblastoma cells
por: Deng, Defeng, et al.
Publicado: (2020)

MT1X is an oncogene and indicates prognosis in ccRCC
por: Ding, Yanpeng, et al.
Publicado: (2022)

Urinary exosomal long noncoding RNAs serve as biomarkers for early detection of non-small cell lung cancer
por: Lin, Quan, et al.
Publicado: (2021)

Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma
por: Han, Ke‐qi, et al.
Publicado: (2016)

CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
por: Yu, Xin, et al.
Publicado: (2022)

Epstein–Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma
por: Xia, Bing, et al.
Publicado: (2019)

Low NLRP3 expression predicts a better prognosis of colorectal cancer
por: Shi, Feng, et al.
Publicado: (2021)

Identification of CXCL13 as an Immune-Related Biomarker Associated with Tumorigenesis and Prognosis in Cutaneous Melanoma Patients
por: Si, Zebing, et al.
Publicado: (2021)

Neutrophil–lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC)
por: Xiang, Zi-jun, et al.
Publicado: (2020)

DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia
por: Sun, Guo‐Kang, et al.
Publicado: (2019)

Former smokers with non‐small‐cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis
por: Zheng, Shanbo, et al.
Publicado: (2016)

CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
por: Zajkowska, Monika, et al.
Publicado: (2023)

GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome
por: Zhou, Jing‐Dong, et al.
Publicado: (2016)

Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
por: Pinter, Matthias, et al.
Publicado: (2017)

High expression of DJ‐1 promotes growth and invasion via the PTEN‐AKT pathway and predicts a poor prognosis in colorectal cancer
por: Lin, Yong, et al.
Publicado: (2018)

Epidemiological trends, relative survival, and prognosis risk factors of WHO Grade III gliomas: A population‐based study
por: Fang, Jun‐Hao, et al.
Publicado: (2019)

Modulation of CXCL-8 expression in human melanoma cells regulates tumor growth, angiogenesis, invasion, and metastasis
por: Wu, Sheng, et al.
Publicado: (2012)

Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma
por: Xue, Li‐Jun, et al.
Publicado: (2017)

Screening and identification of LMNB1 and DLGAP5, two key biomarkers in gliomas
por: Zhou, Ding, et al.
Publicado: (2021)

Cytochrome c in cancer therapy and prognosis
por: Pessoa, João
Publicado: (2022)

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer
por: Liang, Yuan-ke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kisg4v4v69gv8bmi3690grt0sa